"Nasal Sprays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pharmacologic agents delivered into the nostrils in the form of a mist or spray.
| Descriptor ID |
D059085
|
| MeSH Number(s) |
D20.280.055.500 D26.255.165.055.291
|
| Concept/Terms |
Nasal Sprays- Nasal Sprays
- Sprays, Nasal
- Nasal Mist
- Mist, Nasal
- Nasal Aerosol
- Aerosol, Nasal
|
Below are MeSH descriptors whose meaning is more general than "Nasal Sprays".
Below are MeSH descriptors whose meaning is more specific than "Nasal Sprays".
This graph shows the total number of publications written about "Nasal Sprays" by people in this website by year, and whether "Nasal Sprays" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 3 | 3 | 6 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Nasal Sprays" by people in Profiles.
-
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses. 2021 08 20; 13(8).
-
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data. Pharmacol Res Perspect. 2021 08; 9(4):e00810.
-
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. Int J Nanomedicine. 2021; 16:4063-4072.
-
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial. Int Immunopharmacol. 2021 Sep; 98:107871.
-
Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients". Am J Otolaryngol. 2021 Sep-Oct; 42(5):103103.
-
Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2. Adv Mater. 2021 Jul; 33(26):e2008304.
-
Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection. J Infect. 2021 08; 83(2):237-279.
-
Effectiveness of hydrogen peroxide as auxiliary treatment for hospitalized COVID-19 patients in Brazil: preliminary results of a randomized double-blind clinical trial. Epidemiol Health. 2021; 43:e2021032.
-
A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions. Drug Res (Stuttg). 2021 Jul; 71(6):348-350.
-
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients. Am J Otolaryngol. 2021 Jul-Aug; 42(4):103009.